You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 13.3% |
| Div Cover | n/a | -3.2 |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -0.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 1.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -102.0% |
| DPS | n/a | -50.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 5.03 | 1.63 | 1.92p | 5.6 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.10 | -4.10 | -3.45p | -3.8 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -4.79 | -3.53p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -17.73 | -9.46p | -16.2 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -57.86 | -24.28p | -8.6 | 0.0 | n/a | n/a | 0.0% |
| Synairgen posts positive results for phase 2 trial with SNG001 against Covid-19 Sharecast News | 04 Oct |
|---|---|
| Synairgen unveils positive clinical trial data Sharecast News | 07 Sep |
| Synairgen to collaborate with University of Southampton on observational study Sharecast News | 05 Sep |
| Second Price Monitoring Extn | 08-Nov-22 00:00 |
|---|---|
| Price Monitoring Extension | 07-Nov-22 23:59 |
| Second Price Monitoring Extn | 03-Nov-22 23:58 |
| Price Monitoring Extension | 03-Nov-22 23:58 |
| Price Monitoring Extension | 21-Oct-22 00:03 |